Navigation Links
Diabetes II May Be Controlled By Sanofi's New Obesity Pill

Sanofi-Aventis' Accomplia (rimonabant), a new drug for treatment of obesity, has been found to control blood sugar and reduce risk of cardiac problems// in people with diabetes type 2. The research was done on 1,047 overweight or obese patients with type 2 diabetes in Europe and south and North America.

Some of them were given 5 or 20 mg/day of rimonabant, while the others were treated with a placebo, for a 1 year period. Those on the drug showed a vast improvement in terms of weight loss, abdominal fat and waist size reduction and controlled blood sugar levels, and better appetite.

Professor Andre Scheen of the University of Liege in Belgium said that these findings support the usage of 20 mg of the drug daily, along with diet and exercise for treating the disease. The findings have been published online by the Lancet Medical Journal.

These effects of Accomplia reduce the risk of heart disease , stroke, renal damage, blindness and neuropathy which can lead to amputation of the foot. About 194 million people worldwide have diabetes mostly of the type 2 variety . This type is caused by an inability to regulate the glucose in the body properly, and is linked to being overweight or obese.

The standard drugs used are effective in controlling blood sugar levels but lead to weight gain, which makes the illness difficult to treat. Accomplia with its cardiovascular and metabolic effect could prove to be very useful , felt Scheen. It is generally well tolerated , the side effects being nausea, vomiting and anxiety.

The drug has a potential sales of over $3 billion worldwide and Sanofi considers it as its most promising new drug. It is being marketed in Britain, Denmark, Germany, Norway, Ireland, Finland and Austria.
MAL
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... 25, 2016 , ... Today American University of Antigua (AUA) ... announced the AUA-FIU Global MD Program. Students in the Global MD Program ... a Certificate of Completion from the FIU Herbert Wertheim College of Medicine Clinical ...
(Date:5/25/2016)... ... ... Today Omega Institute, a leading destination for yoga education in New York’s Hudson ... the growing field of yoga therapy . Yoga therapy adapts the practice of ... injuries, illnesses, and temporary or chronic health conditions. , “Yoga therapy is a complementary ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today announced ... wellness offerings of Europe, a continent that pioneered the medical/wellness concept for the world. ... pioneers in medical wellness, including Henri Chenot, Founder of the Chenot Group, which operates ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering comprehensive ... Prescription Drug survey , an employee benefits survey measuring how Central ... December 2015, indicates that employers are turning to consumer directed health care and ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & ... turn back the hands of time of female aging. The Juliet™ ... Women with symptoms such as leakage, laxity, itchiness and pain have reported real relief ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today ... programs. The hands-on learning experience is a 12-week summer ... Fellowship and Internship programs bring ... and interns are provided optional housing free of charge ... at the Riverfront Residence Hall to foster communication and ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... WASHINGTON , May 23, 2016 The World ... PrePex device to include adolescents aged 13 years, ... MedTech, can be offered for adult and adolescent males in ... Africa . PrePex was the first male circumcision device ... Circ MedTech,s CEO, Eddy Horowitz said: " The ...
Breaking Medicine Technology: